Merck remains confident as Keytruda faces loss of exclusivity, projecting growth through expanded indications and robust pipeline advancements, underscoring resilience amid increasing market competition.
Browsing: Keytruda
Merck remains confident as Keytruda faces loss of exclusivity, projecting growth through expanded indications and robust pipeline advancements, underscoring resilience amid increasing market competition.